Home › Funds › Avidity Partners Management LP › PVLA

Avidity Partners Management LP position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

Avidity Partners Management LP reported holding 70,000 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 1.71% of its reported portfolio and ranking #8 among its reported holdings. Avidity Partners Management LP has disclosed PVLA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)70.00K sh
Reported value held$10.70M
Portfolio Weight1.71%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Avidity Partners Management LP's PVLA position evolved

Avidity Partners Management LP first disclosed a stake in PVLA in Q4 2025 at 19,300 shares (US$2.0M). The position peaked in Q2 2026 at 70,000 shares, worth US$10.7M. Across 3 filings, Avidity Partners Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 70,000 shares valued at US$10.7M. Notable position changes include a 263% increase in Q1 2026 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 19.30K $2.02M New
Q1 2026 70.00K $8.73M Add
Q2 2026 70.00K $10.70M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has Avidity Partners Management LP held PVLA?

Avidity Partners Management LP has disclosed PVLA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Avidity Partners Management LP's current position in PVLA?

As of Q2 2026, Avidity Partners Management LP holds 70.00K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $10.70M, representing 1.71% of its reported portfolio and ranking #8.

Has Avidity Partners Management LP been buying or selling PVLA?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP held unchanged its position in PVLA. The position peaked in Q2 2026 at 70.00K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.